| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 30.13 | 26.09 | 12.77 | 19.85 | 16.59 | 16.85 | 40.90 |
| Depreciation & Amort ($Mil): | 2.57 | 2.57 | 3.45 | 3.57 | 4.49 | 3.54 | 4.03 |
| Operating Income ($Mil): | -56.88 | -46.65 | -39.41 | -19.61 | -26.88 | -21.13 | -26.06 |
| Net Income ($Mil): | -75.95 | -56.18 | -50.32 | -30.94 | -33.11 | -26.81 | -26.81 |
| Earnings Per Share ($): | -1.24 | -1.06 | -1.18 | -0.87 | -1.06 | -0.32 | -1.36 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 80.79 | 70.09 | 63.76 | 58.63 | 63.56 | 49.34 | 41.78 |
| Current Liabilities ($Mil): | 48.13 | 16.97 | 17.39 | 16.87 | 16.72 | 21.89 | 24.09 |
| Long Term Debt ($Mil): | 50.58 | 30.01 | 33.21 | 2.81 | 3.64 | 3.64 | 17.94 |
| Shares Outstanding (000): | 60650 | 60420 | 43960 | 38020 | 31530 | 24640 | 19700 |
| Common Equity ($Mil): | -27.96 | 29.49 | 23.46 | 40.93 | 47.83 | 33.94 | 30.84 |
| Sep 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -252.07 | -215.33 | -394.05 | -155.87 | -199.58 | -43.98 | -65.55 |
| Return on Equity (%): | -461.22 | -190.51 | -214.49 | -75.59 | -69.22 | -21.83 | -86.93 |
| Return on Assets (%): | -80 | -67.19 | -57.07 | -40.76 | -40.01 | -10.70 | -36.28 |
| P/E Ratio: | 0 | -3.77 | -3.30 | -5.71 | -9.22 | -11.75 | 0.00 |
| Price/Book: | 0 | 8.20 | 7.29 | 4.62 | 6.44 | 2.73 | 0.00 |
| Debt Equity: | -1.81 | 1.02 | 1.42 | 0.07 | 0.08 | 0.11 | 0.58 |
| Interest Coverage: | 0.00 | -5.20 | -12.28 | -28.47 | -31.46 | -17.55 | -20.11 |
| Book Value ($): | -0.46 | 0.49 | 0.53 | 1.08 | 1.52 | 1.38 | 1.57 |
| Price/Sales: | 9.49 | 6.50 | 13.39 | 9.52 | 18.57 | 5.50 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN | +5.10 | 55.47 | |
| GILEAD SCIENCES | -8.10 | 44.45 | |
| CELGENE CP | -16.20 | 55.97 | |
| BIOGEN IDEC INC | -30.20 | 44.26 | |
| GENENTECH INC | +4.70 | 80.36 |
